戻る Agenda
The Metamorphosis of Clinical Trials: Evolving Roles of Stakeholders in Digital Trials
Session Chair(s)
Josh Rose, MBA
Chief Executive Officer
Hawthorne Effect, United States
This session will examine the promise of virtual trials to address challenges of traditional site-based models by examining the evolving roles of study stakeholders, patients, investigators, and study managers, and how they improve study performance
Learning Objective : Describe the potential promise, benefits, and considerations of virtual clinical trials to address challenges to clinical trial conduct and participation; Define the evolution of stakeholder roles, existing and new, and the interplay between them, in virtual/direct to patient clinical trials; Apply insights to inform virtual trial design and planning.
Speaker(s)
Panelist
Angela Botto-van Bemden, PHD
Musculoskeletal Research International, United States
Director, OA Programs
Panelist
Jeff Kingsley, DO, MBA
IACT Health, United States
Chief Executive Officer
Panelist
Christina Markus, JD
King & Spalding LLP, United States
Partner, FDA and Life Sciences
Panelist
Robert Goldman, PHD
Sunovion, United States
Head of Global Clinical Research & Medical Affairs